Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Identifying the Steps Required to Effectively Implement Next-Generation Sequencing in Oncology at a National Level in Europe
Denis Horgan, Giuseppe Curigliano, Olaf Rieß, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 1, pp. 72-72
Open Access | Times Cited: 47

Showing 1-25 of 47 citing articles:

Fusion‐positive non‐small cell lung carcinoma: Biological principles, clinical practice, and diagnostic implications
Daniel Kazdal, Véronique Hofman, Petros Christopoulos, et al.
Genes Chromosomes and Cancer (2022) Vol. 61, Iss. 5, pp. 244-260
Closed Access | Times Cited: 46
The Future of Precision Oncology
Stuart L. Rulten, Richard Grose, Susanne A. Gatz, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 16, pp. 12613-12613
Open Access | Times Cited: 23
Validation and Implementation of a Somatic-Only Tumor Exome for Routine Clinical Application
Parth Shah, Edward G. Hughes, Shrey Sukhadia, et al.
Journal of Molecular Diagnostics (2024) Vol. 26, Iss. 9, pp. 815-824
Open Access | Times Cited: 12
Recommendations for reporting tissue and circulating tumour (ct)DNA next-generation sequencing results in non-small cell lung cancer
Umberto Malapelle, Natasha B. Leighl, Alfredo Addeo, et al.
British Journal of Cancer (2024) Vol. 131, Iss. 2, pp. 212-219
Open Access | Times Cited: 10
Assessing the Cost-Effectiveness of Next-Generation Sequencing as a Biomarker Testing Approach in Oncology and Policy Implications: A Literature Review
Myriam Mirza, Lutz Goerke, Anna Anderson, et al.
Value in Health (2024) Vol. 27, Iss. 9, pp. 1300-1309
Closed Access | Times Cited: 9
Real-world EGFR testing practices for non-small-cell lung cancer by thoracic pathology laboratories across Europe
Paul Hofman, Fiorella Calabrese, Izidor Kern, et al.
ESMO Open (2023) Vol. 8, Iss. 5, pp. 101628-101628
Open Access | Times Cited: 17
Setting Up an Ultra-Fast Next-Generation Sequencing Approach as Reflex Testing at Diagnosis of Non-Squamous Non-Small Cell Lung Cancer; Experience of a Single Center (LPCE, Nice, France)
Marius Ilié, Véronique Hofman, Christophe Bontoux, et al.
Cancers (2022) Vol. 14, Iss. 9, pp. 2258-2258
Open Access | Times Cited: 25
Molecular profiling in cholangiocarcinoma: A practical guide to next-generation sequencing
Albrecht Stenzinger, Arndt Vogel, Ulrich Lehmann, et al.
Cancer Treatment Reviews (2023) Vol. 122, pp. 102649-102649
Open Access | Times Cited: 15
Implementation of Precision Oncology in Clinical Practice: Results of a National Survey for Health Care Professionals
Gianpiero Fasola, Maria Carla Barducci, Giacomo Pelizzari, et al.
The Oncologist (2023) Vol. 28, Iss. 6, pp. e324-e330
Open Access | Times Cited: 13
Role of genomics in liver transplantation for cholangiocarcinoma
Nadine Soliman, Anaum Maqsood, Ashton A. Connor
Current Opinion in Organ Transplantation (2025)
Closed Access
Accelerating the Development and Validation of Liquid Biopsy for Early Cancer Screening and Treatment Tailoring
Denis Horgan, Tanja Čufer, Francesco Gatto, et al.
Healthcare (2022) Vol. 10, Iss. 9, pp. 1714-1714
Open Access | Times Cited: 20
Precision Oncology: A Global Perspective on Implementation and Policy Development
Denis Horgan, Marcel Tanner, Charu Aggarwal, et al.
JCO Global Oncology (2025), Iss. 11
Open Access
Proposal of real-world solutions for the implementation of predictive biomarker testing in patients with operable non-small cell lung cancer
Paul Hofman, Petros Christopoulos, Nicky D’Haene, et al.
Lung Cancer (2025), pp. 108107-108107
Closed Access
Genetic Profiling of Acute and Chronic Leukemia via Next-Generation Sequencing: Current Insights and Future Perspectives
Laras Pratiwi, Fawzia Hanum Mashudi, Mukti Citra Ningtyas, et al.
Hematology Reports (2025) Vol. 17, Iss. 2, pp. 18-18
Open Access
An Idealized Clinicogenomic Registry to Engage Underrepresented Populations Using Innovative Technology
Patrick Silva, Deborah Vollmer Dahlke, Matthew Lee Smith, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 5, pp. 713-713
Open Access | Times Cited: 16
Supporting Biomarker-Driven Therapies in Oncology: A Genomic Testing Cost Calculator
Albrecht Stenzinger, Brian J. Cuffel, Noman Paracha, et al.
The Oncologist (2023) Vol. 28, Iss. 5, pp. e242-e253
Open Access | Times Cited: 10
Socioeconomic disparities and the genomic landscape of gastric cancer
Daniel Zanabria, Marco Gálvez-Niño, Jhajaira M. Araujo, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 3
The use of minimal residual disease in thoracic oncology: Gaps between promises and the on‐the‐ground reality of daily practice
Paul Hofman, Marc G. Denis
Cytopathology (2023) Vol. 35, Iss. 1, pp. 7-15
Open Access | Times Cited: 8
MicroRNA targeting: A novel therapeutic intervention for ovarian cancer
Elmira Roshani Asl, Sajed Sarabandi, Behrouz Shademan, et al.
Biochemistry and Biophysics Reports (2023) Vol. 35, pp. 101519-101519
Open Access | Times Cited: 8
Molecular Profiling in Non-Squamous Non-Small Cell Lung Carcinoma: Towards a Switch to Next-Generation Sequencing Reflex Testing
Nina Pujol, Simon Heeke, Christophe Bontoux, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 10, pp. 1684-1684
Open Access | Times Cited: 13
Actionable mutational profiling in solid tumors using hybrid‐capture‐based next‐generation sequencing in a real‐world setting in Spain
Sandra Zazo, Sandra Pérez‐Buira, Nerea Carvajal, et al.
Cancer Medicine (2024) Vol. 13, Iss. 3
Open Access | Times Cited: 2
Daily Practice Assessment of KRAS Status in NSCLC Patients: A New Challenge for the Thoracic Pathologist Is Right around the Corner
Christophe Bontoux, Véronique Hofman, Patrick Brest, et al.
Cancers (2022) Vol. 14, Iss. 7, pp. 1628-1628
Open Access | Times Cited: 12
Fighting Cancer around the World: A Framework for Action
Denis Horgan, Rizwana Mia, Tosan Erhabor, et al.
Healthcare (2022) Vol. 10, Iss. 11, pp. 2125-2125
Open Access | Times Cited: 9
Clouds across the new dawn for clinical, diagnostic and biological data: accelerating the development, delivery and uptake of personalized medicine
Denis Horgan, Ettore Capoluongo, France Dube, et al.
Diagnosis (2023) Vol. 10, Iss. 4, pp. 356-362
Open Access | Times Cited: 4
Abnormalities in the KRAS Gene and Treatment Options for NSCLC Patients with the G12C Mutation in This Gene—A Literature Review and Single-Center Experience
Anna K. Rekowska, Piotr Rola, Agnieszka Kwiatkowska, et al.
Biomedicines (2024) Vol. 12, Iss. 2, pp. 325-325
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top